EMEA-000828-PIP06-18
Key facts
| Invented name |
Jardiance
|
| Active substance |
empagliflozin
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/0082/2019
|
| PIP number |
EMEA-000828-PIP06-18
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of chronic kidney disease
|
| Route(s) of administration |
Oral use
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|